ASB16-AS1

Across TCGA pan-cancer cohorts, ASB16-AS1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated ASB16-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ASB16-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ASB16-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

KIRC, ACC, and BLCA are the cancer types where ASB16-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.753	0.849	<.001	123	view →
ACC	DFS	Tertile	All	0.209	0.685	<.001	59	view →
BLCA	OS	Quartile	All	0.781	0.614	.004	44	view →
BRCA	OS	Quartile	III,IV	0.968	0.802	<.001	43	view →
LGG	DFS	Median	All	0.644	0.825	<.001	43	view →
PAAD	DFS	Tertile	All	0.421	0.161	<.001	37	view →
COAD	DFS	Tertile	All	0.676	0.873	<.001	31	view →
KICH	OS	Quartile	All	0.539	1.000	.005	28	view →
KIRP	DFS	Quartile	All	0.868	0.965	.025	24	view →
LIHC	DFS	Median	All	0.458	0.625	<.001	23	view →
MESO	DFS	Median	II,III,IV	0.291	0.570	.019	21	view →
HNSC	OS	Tertile	All	0.823	0.712	.018	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

ASB16-AS1–KIRC (DFS)

Open the KIRC breakdown →